Lantheus Holdings (LNTH) Amortization of Deferred Charges (2016 - 2026)
Lantheus Holdings (LNTH) posted quarterly Amortization of Deferred Charges of $1.1 million for Q1 2026, little changed year-over-year from $1.1 million in Q1 2025, and little changed quarter-over-quarter from $1.1 million in Q4 2025.
Lantheus Holdings (LNTH) Amortization of Deferred Charges (2016 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Amortization of Deferred Charges for 11 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortization of Deferred Charges changed 0.0% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $4.5 million (up 2.74% YoY), while the FY2025 annual figure was $4.5 million, up 3.75% from the prior year.
- Amortization of Deferred Charges was little changed at $1.1 million in Q1 2026 per LNTH's latest filing, from $1.1 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $1.1 million in Q1 2025 and bottomed at $245000.0 in Q2 2022.
- Historically, Amortization of Deferred Charges has averaged $906882.4 across 5 years, with a median of $1.1 million in 2023.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges jumped 503.28% — and 2024, when it retreated 0.83%.
- Lantheus Holdings' Amortization of Deferred Charges stood at $512000.0 in 2022, then soared by 109.57% to $1.1 million in 2023, then grew by 0.56% to $1.1 million in 2024, then grew by 3.24% to $1.1 million in 2025, then gained by 0.09% to $1.1 million in 2026.
- Business Quant data shows LNTH's Amortization of Deferred Charges at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.07 Mn |